Jonathan Jacobs, Ph.D., has 20 years of experience in bioinformatics, molecular genetics and microbial genomics. In 1999, he received his BSc. in plant biology from the University of Arizona and later his Ph.D. in molecular genetics and cell biology from the University of Maryland. Later, Dr. Jacobs received postdoctoral training at the NIH's National Cancer Institute, where his research focused on epigenetic control of gene expression in human oncology model systems. Following his postdoc, Dr. Jacobs joined MedImmune where he developed novel technologies in cell line engineering that resulted in multiple patent applications. In 2010, he joined MRIGlobal to build and lead a team focused on microbial forensics and pathogen genomics. Dr. Jacobs joined QIAGEN in 2018, and is the Director of Global Product Management, Genomic Analysis for QIAGEN Digital Insights, where he is directing the development of QIAGEN's CLC software portfolio, a widely used commercial bioinformatics platform.